MedPlus Health Services’ subsidiary, Optival Health Solutions Private Limited, has been served a three-day suspension order for a Drug License at a store in Baragarh, Odisha. The suspension, effective from March 10, 2026, relates to alleged contraventions under the Drugs and Cosmetics Act, 1940. The company anticipates a potential revenue loss of Rs 1.38 lakhs due to this temporary shutdown.
Regulatory Action Against Subsidiary
MedPlus Health Services Limited has disclosed that its subsidiary, Optival Health Solutions Private Limited, has received a formal suspension order concerning a Drug License for one of its retail outlets located in Odisha. The announcement was made on March 10, 2026.
Details of the Suspension Order
The Licensing Authority in the Drugs Control zone, Sambalpur, Odisha, initiated the action. The order mandates the suspension of the Drug License for three days for the store situated opposite the Private Bus stand in Baragarh, Odisha. The authority transmitted the final order received by the subsidiary on March 9, 2026.
Compliance and Impact Assessment
The alleged violation cited relates to the provisions under Rule 65 of the Drugs and Cosmetics Act, 1940, and the accompanying Rules of 1945. MedPlus has quantified the financial impact of this three-day operational halt, estimating a Potential Revenue Loss of Rs 1.38 lacs. The company affirmed that this matter is quantifiable and provided the requisite disclosure as per regulatory guidelines.
The complete filing is available on the company’s official website and the websites of the designated Stock Exchanges.
Source: BSE
